Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Connexin-26 gene mutations may increase cancer risk in KID syndrome patients.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Multiphoton microscopy effectively images rabbit skin structures in detail without staining and shows differences from human skin.

Certain genetic changes in the KRT82 gene may cause patchy skin in New Zealand rabbits.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Lrig1 could be a marker for advanced sebaceous carcinoma.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Targeting colon cancer stem cells might lead to better treatment results.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.

The research cloned keratin 7 genes from humans, mice, and marsupials, found similarities between human and mouse genes, and discovered new areas of K7 expression in mice.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

RANKL causes lymph nodes to grow by making certain cells multiply.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

Patients with certain FoxN1 gene mutations have severe immune issues but normal skin and hair.

The surrounding tissue plays a crucial role in the growth and spread of skin cancer.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

Autoimmune reactions may cause both alopecia areata and HAM.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.